Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

Menarini Group News

2018 - 03 - 22

Menarini announces new governance

 

Florence, 22/03/2018 -  Pharmaceutical group Menarini, headed by the Aleotti family, has decided to entrust the Chairmanship of the company to an external manager coming from a large multinational, Dr. Eric Cornut. The new chairmanship will come into effect as of June.

 

 

The announcement to the employees and the press was made by Lucia Aleotti herself, current Chairman of the pharmaceutical group, together with her brother, Alberto Giovanni, Vice Chairman.

 

 “Entrusting the Chairmanship of the company to an external manager of great experience has been a well thought-out and shared decision made with the entire Board of Directors, in line with our philosophy to rapidly respond to the signs coming from the competitive environment in which we operate” declared Lucia Aleotti. “Menarini is growing in many different  geographical areas and new fields of research, both pharmaceutical and technological. Eric Cornut has already acquired a deep and wide-ranging experience in these areas and will be able to give a further boost to the company.”

 

No withdrawal from the company by Aleotti family: ”On the contrary. We will be able to dedicate more time and greater energy to the search for possible strategic acquisitions, combining the dynamism and the values of a family-owned company with the experience of the future Chairman,” confirmed Alberto Giovanni Aleotti.

 



Eric Cornut stated: “I first came to appreciate Menarini as an external observer, then as a member of the Board of Directors, with an ever-increasing appreciation of the values and philosophy which make it a rather unique company on an international level, with an enviable potential for development. I am honoured to be able to contribute towards the evolution and growth of the company.”